CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr | ₹223 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹192 Cr |
Mar2022 | ₹344 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹223 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -25.90 | |
Mar2023 | ₹192 Cr | -44.27 | |
Mar2022 | ₹344 Cr | 45.91 | |
Mar2021 | ₹236 Cr | 5.67 | |
Mar2020 | ₹223 Cr | - |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹21,939.3 Cr | 3.3% | 0.5% | 49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 3.3% |
0.5% |
49.3% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses